Governance
To ensure that ConcePTION operates in a transparent and efficient manner ConcePTION has a multi-layered governance structure (see figure).
The consortium, comprising close to 200 researchers, is governed and managed by a balanced 50/50 split of public and private partners, and is jointly led by Novartis and the University Medical Center Utrecht.
| WP | Public Lead | EFPIA lead |
| 1 | Dr. Amanda Neville (University of Ferrara) | Dr. Anja Geldhof (Janssen Pharmaceutica NV) |
| 2 | Dr. Laura Yates (University of KwaZulu-Natal) | Dr. David Lewis (Novartis Pharma AG) |
| 3 | Prof. dr. Isabelle Huys (KU Leuven) | Dr. Michele Bouisset-Leonard (Novartis Pharma AG) |
| 4 | Prof. dr. Mats Hansson (Uppsala Universitet) | Dr. Marie Teil (UCB biopharma) |
| 5 | Dr. Agnes Kant (Stichting LAREB) | Dr. Stephanie Tcherny-Lessenlot (Sanofi) |
| 6 | Prof. dr. Dipak Kalra (The European Institute for Innovation through Health Data) | Dr. Christine Allan (Takeda) |
| 7 | Prof. dr. Miriam Sturkenboom (UMC Utrecht) | |
| 8 | Dr. Pieter Stolk (UMC Utrecht) | Dr. Michael Steel (Novartis Pharma AG) |